Article

Driving adoption of new technologies in biopharmaceutical manufacturing

2022-11-30

Abstract excerpt

The challenge of introducing new technologies into established industries is not a problem unique to the biopharmaceutical industry. However, it may be critical to the long-term competitiveness of individual manufacturers and, more importantly, the ability to deliver therapies to patients. This is especially true for new treatment modalities including cell and gene therapies. We review several barriers to technolo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 00d19e8a-2462-5a66-94ed-3f43ba60cc73
DOI: 10.22541/au.166980426.65269138/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Driving adoption of new technologies in biopharmaceutical manufacturingDOI 10.22541/au.166980426.65269138/v1Read

GMP manufacturing of cell and gene therapy products: Challenges, opportunities, and pathways forwardSemantic proximity Read

Towards a commercial process for the manufacture of genetically modified T cells for therapySemantic proximity Read

Manufacturing Cell and Gene Therapies: Challenges in Clinical TranslationSemantic proximity Read

Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicineSemantic proximity Read

Optimizing regulatory frameworks for gene therapies in rare diseases: Challenges and solutionsSemantic proximity Read

Design tensions in a two-sided marketplace for reusable digital therapeutics software components: a qualitative interview studySemantic proximity Read

Considerations for manufacturing of cell and gene medicines for clinical developmentSemantic proximity Read

Cost of Goods Sold Analysis for Manufacturing mRNA-Based Cell and Gene TherapiesSemantic proximity Read

Fully Integrated downstream process to enable Next Generation ManufacturingSemantic proximity Read

Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: A qualitative studySemantic proximity Read

Exploring Unique Device Identifier Implementation and Use for Real-World Evidence: A Mixed-Methods Study with NESTcc Health System Network CollaboratorsSemantic proximity Read

Bench-to-bedside: Translational development landscape of biotechnology in healthcareSemantic proximity Read